Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Structure/Function Claim Proposal Meeting Slated For Aug. 4

This article was originally published in The Tan Sheet

Executive Summary

The definition of "disease" as it pertains to dietary supplement claims will be re-examined at a public meeting in Washington, D.C. Aug. 4, FDA announced in the July 8 Federal Register. The meeting will address three of the more contentious issues raised in comments on the agency's April 29, 1998 proposed rule on structure/function claims (1"The Tan Sheet" May 4, 1998, pp. 1-5).

You may also be interested in...



Dietary Supplement Implied Disease Claims Still Not Suitable - FDA

FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.

Dietary Supplement Implied Disease Claims Still Not Suitable - FDA

FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.

Dietary Supplement Implied Disease Claims Still Not Suitable - FDA

FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.

Related Content

Topics

UsernamePublicRestriction

Register

PS090040

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel